MedTrace Logo

Vitamin D and Chronic Obstructive Lung Disease

NCT01416701 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2013-04-09

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of vitamin D intervention in patients with chronic obstructive pulmonary disease (COPD) undergoing rehabilitation.

Conditions

  • Chronic Obstructive Lung Disease

Interventions

DIETARY_SUPPLEMENT

Vitamin D (D3, cholecalciferol)

Week 0-4: 152 mcg/daily (4 tablets) Week 5-52: 76 mcg/daily (2 tablets)

DIETARY_SUPPLEMENT

Placebo (cellulose)

Week 0-4: 4 tablets daily Week 4-52: 2 tablets daily

Sponsors & Collaborators

  • Jorgen Vestbo

    lead OTHER

Principal Investigators

  • Jørgen Vestbo, DMSc · Hvidovre Universityl Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416701 on ClinicalTrials.gov